Healthcare
Sigyn Therapeutics
Recorded April 23, 2025
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Sigyn Therapeutics [OTCQB: SIGY] is a pioneering developer of medical devices targeting cancer, infectious diseases, and more
Inner Cosmos has created the world’s first Digital Pill to treat the 7 million patients with drug resistant depression.
Glazd is the first rental insurance agency designed to sell at scale with their one-to-many approach that ensures every renter has a policy
A functional beverage company and CPG accelerator that recently purchased Yerbaé, to help its customers live healthier and happier lives.
Cellibre has developed a platform technology to produce chemicals creating less expensive, higher quality, and more resilient supply chains.
For Family Offices, investing in a sports franchise can provide significant financial returns along with great intangible benefits.
PowerLight’s revolutionary optical energy delivery system is transforming everything from drones and smart grids to space exploration.
The company’s AI-powered drug development program has the potential to uncover treatments for multiple diseases and impact millions of lives.
Heritage Distilling Company (NASDAQ: CASK) is the most awarded craft distillery 10 years in a row.
Nordicus has successively completed its first toxicity study for Orocidin QR-01, a novel treatment for aggressive periodontitis.
Silvanet is a forest fire early warning system that gives fire fighters a chance to extinguish a fire before it spreads.
Seurat’s revolutionary manufacturing process out-competes traditional manufacturing in every way: economics, speed, and quality.